BioRestorative Therapies (OTCMKTS:BRTXQ) Shares Up 1.3% - Should You Buy?

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

BioRestorative Therapies, Inc. (OTCMKTS:BRTXQ - ) shares shot up 1.3% during trading on Monday . The stock traded as high as $1.52 and last traded at $1.52. 25,791 shares changed hands during mid-day trading, a decline of 100% from the average session volume of 62,169,492 shares. The stock had previously closed at $1.50.

BioRestorative Therapies Price Performance

The firm's fifty day simple moving average is $1.60 and its 200 day simple moving average is $1.74. The company has a market capitalization of $2.49 billion, a price-to-earnings ratio of -1.42 and a beta of 102.36.

BioRestorative Therapies Company Profile

BioRestorative Therapies, Inc develops therapeutic products using cell and tissue protocols primarily involving adult stem cells. The company's two core programs are related to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program includes a lead cell therapy candidate, BRTX-100 is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow and intended for the non-surgical treatment of painful lumbosacral disc disorders.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.